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Purpose: This study aimed to develop a multi-channel near-infrared spectroscopy (NIRS) and 
ultrasonography (USG) fusion imaging system for imaging prostate cancer and to verify its 
diagnostic capability by applying the hybrid imaging system to a prostate cancer phantom.
Methods: A multi-channel NIRS system using the near-infrared 785-nm wavelength with 12 
channels and four detectors was developed. After arranging the optical fibers around a USG 
transducer, we performed NIRS imaging and grayscale USG imaging simultaneously. Fusion 
imaging was obtained by processing incoming signals and the spatial reconstruction of NIRS, 
which corresponded with grayscale USG acquired at the same time. The NIRS-USG hybrid system 
was applied to a silicone-based optical phantom of the prostate gland containing prostate 
cancer to verify its diagnostic capability qualitatively.
Results: The NIRS-USG hybrid imaging system for prostate cancer imaging simultaneously 
provided anatomical and optical information with 2-dimensional registration. The hybrid imaging 
system showed more NIR attenuation over the prostate cancer model than over the model of 
normal prostate tissue. Its diagnostic capability to discriminate a focal area mimicking the optical 
properties of prostate cancer from the surrounding background mimicking the optical properties 
of normal prostate tissue was verified by applying the hybrid system to a silicone-based optical 
phantom of prostate cancer.
Conclusion: This study successfully demonstrated that the NIRS-USG hybrid system may serve as 
a new imaging method for improving the diagnostic accuracy of prostate cancer, with potential 
utility for future clinical applications. 
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Introduction
Prostate cancer is the second most frequently diagnosed cancer 
in the male population and the fifth leading cause of cancer 
deaths worldwide [1,2]. Transrectal ultrasound (TRUS)-guided 
prostate biopsy is the standard and most common method for 
detecting prostate cancer in men with elevated serum prostate-
specific antigen levels and/or abnormal digital rectal examination 
findings [3]. Unlike many other solid tumors, for which image-
guided targeted biopsy is common, prostate cancer is detected by 
random sampling of the entire prostate gland because imaging-
based identification of prostate cancer is difficult. Consequently, the 
low cancer detection rate (27%-40%) of TRUS-guided systematic 
random biopsies results in missing a substantial proportion of cases 
of clinically significant prostate cancer [4,5]. 
Near-infrared spectroscopy (NIRS) is an optical method of 
measuring changes in the concentration of chromophores, using 
light with wavelengths in the range of 700-900 nm, which is 
known to move by scattering rather than absorption, enabling it 
to reach deep inside the human body [6]. Since the chromophores 
in the human body consist mostly of oxyhemoglobin and 
deoxyhemoglobin, NIRS signals can reflect the status of biologic 
metabolism inside the human body [7]. In general, malignant tissue 
can be either hypervascular from overstimulated angiogenesis or 
hypovascular due to rapid tissue growth exceeding its vascular 
supply. Prostate cancer is known to show a higher concentration of 
microvasculature than normal prostate tissue [8]. Jiang et al. [9,10] 
demonstrated that NIRS could detect this hemodynamic difference 
between normal prostate tissue and prostate cancer, meaning that 
NIRS could be used to image prostate cancer with higher sensitivity 
and specificity than TRUS. According to their results, however, 
TRUS was more accurate in localizing prostate cancer than NIRS, 
especially in the deep portion of the prostate gland. Therefore, it 
might be possible to improve diagnostic accuracy by combining 
these two modalities. The purpose of this study was to develop an 
NIRS-ultrasonography (USG) hybrid imaging system and to verify its 
diagnostic capability using an optical phantom model of a normal 
prostate gland and prostate cancer. 
Materials and Methods
Institutional review board at our institution approved this study, and 
the requirement for informed consent was waived.
Development of the Multi-channel NIRS-USG Hybrid 
Imaging System
The continuous wave method was used to measure NIRS signals in 
our system, with a wavelength of 785 nm. A total of 12 laser diodes 
(Thorlabs, Newton, NJ, USA) were used as the light source in the 
multi-channel NIRS system. A total of four avalanche photodiodes 
(APDs) (C5460-01, Hamamatsu Photonics, Hamamatsu, Japan) were 
used as detectors to improve the spatial resolution and the field of 
view. After passing the band pass filter, light was demodulated into 
its direct current component by the demodulation circuit using a 
root mean square detector. The signal lost during this demodulation 
process was compensated by a signal amplifier using OP-Amp. 
It then underwent a low-pass filter to remove the remaining 
modulated component. Finally, it was sampled by a data acquisition 
device (PCI-6122, National Instruments, Austin, TX, USA), through 
two channels simultaneously. To determine the switching and 
sampling rates of the laser diodes, a microcontroller unit (MCU) 
(ATmega128) was used. The maximal sampling rate was set at 30 
Hz by the MCU. Optical fibers with a diameter of 400 μm (FT400-
EMT, Thorlabs) were connected to the laser diodes and APDs. The 
intensity of the emitted laser was set between 5 and 7 mW. Labview 
software (National Instruments) was used to develop a graphical 
user interface that could process the incoming signals and display 
them on the same monitor simultaneously. The open-source platform 
Near-Infrared Fluorescence and Spectral Tomography (NIRFAST; 
Dartmouth College and University of Birmingham, Birmingham, UK), 
which simulates light propagation in biological tissue, was used 
for modeling near-infrared (NIR) light transport inside the phantom 
[11,12]. This software, coded on the basis of MATLAB (MathWorks, 
Natick, MA, USA), is capable of retrieving the absorption coefficient 
from single-wavelength light attenuation and reconstructing it into 
2-dimensional (2D) images.
A plastic holder for a high-frequency linear ultrasound (US) 
transducer (12-15 MHz) of an Aixplorer US system (Super-Sonic 
Imagine, Aix-en-Provence, France) was also developed. It contained 
12 holes with the same diameter as the optical fibers along two 
facing long sides with a rectangular shape. These holes were 
designed to hold the optical fibers firmly, preventing them from 
moving during the signal. The arrangement of the sources and 
detectors was also changed to be symmetrical on both sides of 
the plastic holder to minimize the interference caused by nearby 
sources. The hybrid imaging systems were completed by assembling 
a US probe holder, a controllable metal arm with two joints, and a 
platform for a phantom (Fig. 1A, B).
Development of the Optical Phantom Containing a Prostate 
Cancer Model 
A phantom with optical properties mimicking those of a prostate 
gland with prostate cancer inside was developed using TiO2 for 
the scattering effect and India ink for the absorption effect [13]. 
NIRS-USG hybrid imaging for prostate cancer 
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Reference values of the optical properties of normal prostate tissue, 
prostate cancer, and the surrounding muscle layers were selected 
from previous studies [14-18] and expressed by adjusting the 
quantity of TiO2 and India ink. Following the fabrication process, 
a small phantom with optical properties mimicking the prostate 
cancer was made. Then, a larger phantom with optical properties 
mimicking those of a normal prostate gland was developed. During 
the process of making this standard prostate gland phantom, the 
prostate cancer phantom was placed into the mixed silicone before 
it was poured into a mold. Similarly, the larger phantom with 
optical properties similar to those of the muscle layer was made by 
placing the prostate gland phantom that contained the prostate 
cancer phantom into the muscle layer phantom before pouring the 
mixed silicone into a mold. Diagrams of the optical phantoms of the 
prostate gland containing prostate cancer are shown in Fig. 1C. A 
detailed specification of the materials used in phantom development 
is presented in Table 1. 
Verification of the Hybrid Imaging System Using the Optical 
Phantom Model of Prostate Cancer
The US transducer was placed within a plastic holder containing 
a total of 12 optical fibers (8 sources and 4 detectors) over the 
Fig. 1. A near-infrared spectroscopy and ultrasonography hybrid imaging system and the optical phantom of the prostate gland with 
the prostate cancer embedded inside. 
A. Diagram of the plastic holder containing 12 holes is shown. The red holes contained source fibers with a wavelength of 785 nm, while the 
blue holes were for detector fibers. B. The plastic holder with 12 holes, each containing optical fibers is placed on the phantom. C. Developed 
optical phantom of a normal prostate gland with prostate cancer is depicted in this diagram. Blue, gray, and red colors represent the prostate 
gland, muscle layer, and prostate cancer, respectively. The red-colored prostate cancer phantom is embedded inside the optical phantom of a 
normal prostate gland. D. The plastic holder with an ultrasound transducer is placed over the phantom. 
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Fig. 2. Reconstructed 2-dimensional (2D) images, obtained by the near-infrared spectroscopy (NIRS) and ultrasonography (USG) hybrid 
imaging system using an optical prostate phantom. 
A. The left column shows grayscale USG from three different locations of the hybrid probe placed over the prostate cancer. Arrows indicate 
the corresponding reconstructed 2D images from NIRS. The right column shows the reconstructed 2D images based on absorption 
coefficients. B. Overlaid images of the grayscale USG and the reconstructed 2D images are shown. Areas of high absorption coefficients were 
correlated with the location of the prostate cancer model. 
B
Table 1. Detailed specifications of the developed optical phantoms
Size (cm)a) Amount (mL)b) TiO2 (g) India ink (g) μs’ (/cm, 785 nm) μa (/cm, 785 nm)
Prostate cancer 1.2 (w), 1.4 (l), 0.8 (h) 100 0.084 0.054 7.1 0.41
Prostate gland 4.3 (w), 4.5 (l), 5.3 (h) 200 0.252 0.064 10 0.2
Muscle layer 13 (ud), 10 (ld), 6 (h) 275 0.1 0.045 3.06 0.12
TiO2, titanium dioxide; μs’, induced scattering coefficient; μa, absorption coefficient; w, width; l, length; h, height; ud, diameter of the upper face; ld, diameter of the lower face.
a)Final size of a cured phantom. b)Amount of mixed silicone prepared.
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developed phantom, and NIRS signal attenuation and grayscale 
sonograms were obtained simultaneously (Fig. 1D). This hybrid 
imaging was repeated 4 times, and each time the location of the 
plastic holder over the prostate phantom was changed (Fig. 2). 
The collected NIRS signals were used to reconstruct the 2D images 
by modifying the NIRFAST software package, which simulates 
light propagation in biological tissue [11]. Fusion images of the 
reconstructed 2D images from the NIRS system and the cross-
sectional grayscale US images acquired at the same time were 
obtained.
Results
The intensity of the incoming NIR signals was relatively low when the 
hybrid probe was held over the prostate cancer phantom, suggesting 
that more light is absorbed and/or scattered when passing through 
these routes, reflecting the presence of an inner region with different 
optical properties from its surroundings under the location of the 
plastic holder. Rectangular 2D reconstruction images were formed 
iteratively, until the difference between the forward data and 
the reconstructed data did not improve by more than 2% when 
compared with the previous iteration. The final reconstructed 2D 
images based on the absorption coefficients of NIRS are shown in the 
right column of Fig. 2A and overlaid images with grayscale USG are 
shown in Fig. 2B. As we changed the location of the optical fibers, 
the area of high absorption coefficients also changed, suggesting 
the capability of the NIRS system to reliably distinguish inner regions 
with different optical properties. The region with higher absorption 
coefficients was correlated with the location of the embedded 
optical phantom of prostate cancer. The longitudinal sonograms were 
simultaneously obtained during NIRS imaging, and the corresponding 
NIRS region is depicted with arrows in Fig. 2A. Three overlaid images 
of simultaneously obtained USG and the reconstructed 2D images 
are shown in Fig. 2B. Similarly, areas of high absorption coefficients 
were correlated with the location of the prostate cancer. The 
results show that good separation was obtained between the focal 
area mimicking the optical properties of prostate cancer from the 
surrounding background areas mimicking the optical properties of 
normal prostate tissue along the transverse axis. The hybrid imaging 
showed more NIR attenuation over the prostate cancer than over 
the normal prostate tissue, which may indicate its capability to 
discriminate focal areas mimicking prostate cancer from surrounding 
normal prostate tissue.
Discussion
In the present study, we developed a NIRS-USG fusion imaging 
system for prostate cancer imaging. It is non-invasive and 
simultaneously provides anatomical and optical (hemodynamic) 
information. Its diagnostic capability was qualitatively verified by 
applying the hybrid system to a silicone-based optical phantom 
of prostate cancer. The fusion imaging device was fabricated 
by arranging optical fibers around a US transducer. The hybrid 
imaging system showed more NIR attenuation over the prostate 
cancer model than over the normal prostate gland model. Because 
elevation of total hemoglobin levels is related to NIR attenuation, 
NIR imaging can detect tumors with increased vascularity, such 
as prostate cancer. Most of the optical contrast is probably due to 
intrinsic tumor vascularity and tumor-bound chromophores. Prostate 
cancer lesions are known to have a higher density of capillaries than 
the surrounding benign prostate tissue [8,19]. Jiang et al. [9,10] 
demonstrated that NIRS could differentiate prostate cancer from 
the surrounding normal prostate gland using differences in optical 
properties caused by different degrees of vascularity, with better 
sensitivity and specificity than TRUS. It was anticipated that NIRS 
data would provide additional information about the localization 
of focal prostate cancer. This phantom study was an initial step in 
the development of a new NIRS imaging system and the verification 
of its diagnostic capabilities using an optical phantom of prostate 
cancer. 
Kim et al. [18] previously developed an NIRS system used with an 
optical prostate phantom. In this study, the previous NIRS system 
and the fabrication process of optical phantom development were 
upgraded to optimize the system and to minimize the limitations of 
the previous study. First, there were several small air bubbles around 
the border between the normal prostate gland and muscle layer 
portions, which could have been a source of signal noise. A vacuum 
oven and a more powerful vacuum pump were used to minimize the 
air bubbles. Despite using an upgraded vacuum pump to remove the 
air bubbles generated along the interfaces between the two different 
materials during phantom fabrication, USG revealed that sheet-like 
air bubble layers remained along the interfaces between the normal 
prostate gland and the prostate cancer phantoms, which could 
have been the source of reverberation artifacts. Second, the optical 
fibers were not firmly fixed in position in the previous study, possibly 
reducing the reproducibility and reliability of the measurements. 
In the present study, we developed a plastic holder with metal 
arms to place each optical fiber in the same position during the 
measurements, and the received signals were remarkably more 
consistent. Finally, we adopted the NIRFAST algorithm to reconstruct 
2D images, which became possible by adding more detectors to 
improve the spatial resolution and field of view. Therefore, the 
present hybrid system showed more prominent delineation of the 
focal area, with high absorption coefficients, from its surroundings, 
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and the delineated focal area was closely correlated with the actual 
location of the target region. 
Further studies will be performed to develop a clinically feasible 
hybrid imaging system. An animal study using a prostate cancer 
model should be performed to verify the in vivo  diagnostic 
performance of this new imaging modality. As hybrid imaging can be 
performed on in vivo models, as well as artificially developed optical 
phantoms, an algorithm for image registration between NIRS and 
TRUS can be set up and optimized. Finally, a clinical study of prostate 
cancer patients should be conducted to validate and optimize the 
diagnostic performance of this modality on human bodies.
This study demonstrated that our NIRS-USG hybrid imaging 
system may serve as a new imaging method with potential for 
improving diagnostic accuracy in the localization of focal prostate 
cancer. In future, NIRS may be combined with TRUS, improving the 
diagnostic accuracy of prostate cancer imaging and the localization 
of target biopsy sites. This study presented a NIRS-USG hybrid 
imaging system for prostate cancer that was evaluated using a 
phantom, with potential utility for future clinical applications. 
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